Why Life-Science Innovation is Politically Purple
June 28, 2016

Vice President, Global Innovation Policy, and Director, Center for Life Sciences Innovation
Information Technology and Innovation Foundation
Speaker
On June 28, 2016, Stephen Ezell spoke at a Center Forward Congressional briefing on “Why Life-Sciences Innovation is Politically Purple,” explaining that U.S. leadership in global life-sciences innovation has resulted from a strong bi-partisan commitment to support robust levels of public investment in basic life-sciences research while creating an environment in which continued private-sector investment in drug discovery can flourish thanks to strong intellectual property protections and a drug pricing reimbursement system that permits reasonable profits to be reinvested in future generations of biomedical innovation.